Sacituzumab tirumotecan is under clinical development by Merck and currently in Phase II for Gastrointestinal Tract Cancer. According to GlobalData, Phase II drugs for Gastrointestinal Tract Cancer ...
Rifaquizinone is under clinical development by TenNor Therapeutics and currently in Phase I for Irritable Bowel Syndrome.
Biora Therapeutics, a reputable biotech firm listed on the NASDAQ under the ticker BIOR, recently made waves in the financial world by voluntarily filing a petition on December 27, 2024, under Chapter ...
Money Talks News on MSN7h
Eating This Type of Food Is Now Tied to Premature AgingEating a lot of highly processed foods is now associated with a “significant acceleration” of biological aging — a measure of ...
A new class of over-the-counter probiotic supplements claim to prevent hangovers by reducing gut acetaldehyde. Some ...
Hosted on MSN1d
What are the health benefits and risks of using cannabis?Cannabis is a plant that contains dozens of different cannabinoids, the main ones being THC and CBD, which affect the body ...
Discover the top five reasons for bloating and learn effective solutions to relieve discomfort. Get expert tips for better ...
coli and Staphylococcus. These bacteria can cause all sorts of illnesses, from gastrointestinal to urinary tract infections ...
"Bubble butt" can leave turtles struggling to swim normally — or unable to submerge at all. A 3D-printed harness can help.
Undiagnosed or untreated EPI could result in muscle loss since the patient isn’t absorbing the necessary nutrients.
As part of the ongoing Human Cell Atlas project, researchers mapped 1.6 million cells in the gastrointestinal tract. Here’s ...
Gastroenteropancreatic neuroendocrine carcinoma (NEC) represents a challenging subset of extrapulmonary neuroendocrine tumors, predominantly originating in the gastrointestinal tract. These poorly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback